BridgeMD
Corticosteroid in treatment of acute laryngitis among vocal professionals
EU CTIS ID: 2024-512192-12-00
What this study is testing
To find out the efficacy of oral corticosteroid therapy compared with placebo in treatment of acute laryngitis among vocal professionals and singers.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Hoarseness that starts during or after flu symptoms and has lasted for less than three weeks
- Fluency in Finnish language
- Minimum age of 18 years and maximum age of 64 years
- Vocal professionals or those studying to become one
You likely can't join if
- hypersensitivity to the prednisolone
- Contraindication to prednisolone (tuberculosis, acute psychosis, gastric or duodenal ulcer).
- Fungal and/or bacterial laryngitis
- Significant voice symptoms before laryngitis
- Fever (over 38C)
- Pregnancy
See the full eligibility criteria
- Hoarseness that starts during or after flu symptoms and has lasted for less than three weeks
- Fluency in Finnish language
- Minimum age of 18 years and maximum age of 64 years
- Vocal professionals or those studying to become one
- hypersensitivity to the prednisolone
- Contraindication to prednisolone (tuberculosis, acute psychosis, gastric or duodenal ulcer).
- Fungal and/or bacterial laryngitis
- Significant voice symptoms before laryngitis
- Fever (over 38C)
- Pregnancy
- Breastfeeding
- Simultaneous oral bacterial, viral or fungal medication.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.